CLDX Celldex Therapeutics, Inc.
Fundamentals / CIK 0000744218 / USDCelldex Therapeutics, Inc. reported $158K in revenue and a net loss of $309.1M for the trailing twelve months ended September 30, 2026 (down 78.0% year over year), with a 851.3% gross margin and a -211684.8% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CLDX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$158K -78.0% YoY
-
Operating Income TTM-$334.5M -211684.8% margin
-
Net Income TTM-$309.1M -195608.9% net margin
-
Diluted EPS TTM-$3.94 Split-adjusted
-
Free Cash Flow TTM-$259.7M -164391.8% FCF margin
-
Cash & ST Investments Sep 30, 2026$650.3M Total debt: $9.87M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.54M | $7.02M | $6.88M | $2.36M | $4.65M | $7.42M | $3.57M | $9.54M | $12.74M | $6.79M |
| Cost of Revenue | $200K | $200K | $300K | $100K | $100K | $200K | $100K | $700K | $700K | $1.60M |
| Gross Profit | $1.34M | $6.82M | $6.58M | $2.26M | $4.55M | $7.22M | $3.47M | $8.84M | $12.04M | $5.19M |
| Research & Development | $245.1M | $163.6M | $118.0M | $82.26M | $53.31M | $42.53M | $42.67M | $66.45M | $96.17M | $102.7M |
| Operating Income | -$287.4M | -$195.1M | -$154.5M | -$115.2M | -$71.24M | -$63.35M | -$55.03M | -$156.4M | -$121.5M | -$132.9M |
| EBITDA | -$284.0M | -$191.9M | -$151.5M | -$112.3M | -$68.17M | -$59.42M | -$50.17M | -$152.9M | -$117.1M | -$129.8M |
| Income Before Tax | -$258.8M | -$157.9M | -$141.4M | -$112.3M | -$70.74M | -$60.95M | -$50.88M | -$151.9M | -$117.3M | -$128.5M |
| Income Tax Expense | $0 | $0 | $0 | -- | -$227K | -$1.17M | -- | -$765K | -$24.28M | -- |
| Net Income | -$258.8M | -$157.9M | -$141.4M | -$112.3M | -$70.51M | -$59.78M | -$50.88M | -$151.2M | -$93.03M | -$128.5M |
| Basic EPS | -$3.90 | -$2.45 | -$2.92 | -$2.40 | -$1.64 | -$2.02 | -$3.51 | -$14.48 | -$10.86 | -$18.99 |
| Diluted EPS | -$3.90 | -$2.45 | -$2.92 | -$2.40 | -$1.64 | -$2.02 | -$3.51 | -$14.48 | -$10.86 | -$18.99 |
| Basic Shares Outstanding | 66.4M | 64.4M | 48.4M | 46.9K | 42.9K | 29.6K | 14.5K | 10.4K | 8.6M | 6.8M |
| Diluted Shares Outstanding | 66.4M | 64.4M | 48.4M | 46.9K | 42.9K | 29.6K | 14.5K | 10.4K | 8.6M | 6.8M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $22K | $15K | $121K | $0 | $730K | $695K | $1.18M |
| Research & Development | $67.41M | $67.54M | $73.00M | $75.33M | $62.93M | $54.20M | $52.61M | $46.94M |
| Operating Income | -$82.25M | -$80.62M | -$84.44M | -$87.15M | -$73.62M | -$63.86M | -$62.74M | -$56.03M |
| EBITDA | -$81.09M | -$79.72M | -$83.58M | -$86.34M | -$72.79M | -$62.98M | -$61.87M | -$55.21M |
| Net Income | -$75.56M | -$73.50M | -$78.69M | -$81.32M | -$67.04M | -$56.60M | -$53.80M | -$47.09M |
| Basic EPS | -$0.96 | -$0.94 | -$1.18 | -- | -$1.01 | -$0.85 | -$0.81 | -- |
| Diluted EPS | -$0.96 | -$0.94 | -$1.18 | -- | -$1.01 | -$0.85 | -$0.81 | -- |
| Basic Shares Outstanding | 78.5M | 77.8M | 66.6M | -- | 66.4M | 66.4M | 66.4M | -- |
| Diluted Shares Outstanding | 78.5M | 77.8M | 66.6M | -- | 66.4M | 66.4M | 66.4M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $28.87M | $28.36M | $34.81M | $29.43M | $39.14M | $43.84M | $11.23M | $24.31M | $40.29M | $42.46M |
| Short-Term Investments | $489.7M | $696.9M | $388.8M | $275.5M | $369.1M | $150.6M | $53.15M | $69.71M | $99.14M | $147.3M |
| Cash & Short-Term Investments | $518.6M | $725.3M | $423.6M | $305.0M | $408.2M | $194.4M | $64.38M | $94.02M | $139.4M | $189.8M |
| Total Current Assets | $534.7M | $747.2M | $431.7M | $317.7M | $410.8M | $197.8M | $66.70M | $99.08M | $144.8M | $195.6M |
| Property, Plant & Equipment, Net | $5.33M | $4.35M | $4.06M | $3.75M | $3.55M | $3.81M | $4.03M | $6.11M | $10.37M | $13.19M |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | -- | $90.98M | $90.98M |
| Intangible Assets | $27.19M | $27.19M | $27.19M | $27.19M | $27.19M | $30.69M | $48.69M | $48.69M | $67.59M | $81.49M |
| Other Non-Current Assets | $13.36M | $9.75M | $107K | $104K | $104K | $41K | $41K | $1.93M | $1.93M | $2.13M |
| Total Non-Current Assets | $48.32M | $45.18M | $33.93M | $35.04M | $33.81M | $37.99M | $56.23M | $56.73M | $170.9M | $187.8M |
| Total Assets | $583.0M | $792.3M | $465.6M | $352.7M | $444.7M | $235.8M | $122.9M | $155.8M | $315.6M | $383.4M |
| Accounts Payable | $1.18M | $3.27M | $3.49M | $3.34M | $1.23M | $1.05M | $1.17M | $1.07M | $1.72M | $1.74M |
| Other Current Liabilities | $1.23M | $942K | $3.99M | $990K | $1.55M | $3.37M | $2.03M | $4.53M | $6.57M | $4.83M |
| Total Current Liabilities | $50.99M | $39.50M | $31.12M | $18.61M | $16.53M | $14.21M | $11.64M | $12.60M | $27.74M | $35.22M |
| Other Non-Current Liabilities | $4.04M | $3.47M | $4.40M | $5.33M | $7.35M | $10.12M | $15.55M | $19.15M | $51.52M | $82.70M |
| Total Non-Current Liabilities | $4.83M | $5.83M | $5.33M | $7.92M | $8.65M | $12.28M | $17.26M | $19.15M | $51.52M | $82.70M |
| Total Liabilities | $55.82M | $45.34M | $36.46M | $26.53M | $25.18M | $26.48M | $28.91M | $31.75M | $79.25M | $117.9M |
| Total Debt (incl. Leases) | $2.34M | $3.81M | $2.54M | $4.03M | $3.04M | $3.48M | $3.66M | -- | -- | -- |
| Common Stock | $67K | $66K | $56K | $47K | $47K | $40K | $17K | $12K | $9.0K | $121K |
| Retained Earnings | -$1.81B | -$1.56B | -$1.40B | -$1.26B | -$1.14B | -$1.07B | -$1.01B | -$962.4M | -$812.5M | -$719.5M |
| Accumulated Other Comp. Income | $3.63M | $3.31M | $3.31M | $1.26M | $1.89M | $2.59M | $2.62M | $2.58M | $2.56M | $2.54M |
| Total Stockholders' Equity | $527.2M | $747.0M | $429.2M | $326.2M | $419.5M | $209.4M | $94.03M | $124.1M | $236.4M | $265.4M |
| Total Equity | $527.2M | $747.0M | $429.2M | $326.2M | $419.5M | $209.4M | $94.03M | $124.1M | $236.4M | $265.4M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $26.95M | $47.45M | $35.73M | $28.87M | $36.04M | $23.04M | $17.14M | $28.36M |
| Short-Term Investments | $623.4M | $670.1M | $415.7M | $489.7M | $547.2M | $607.3M | $656.2M | $696.9M |
| Cash & Short-Term Investments | $650.3M | $717.6M | $451.5M | $518.6M | $583.2M | $630.3M | $673.3M | $725.3M |
| Total Current Assets | $663.7M | $724.9M | $459.2M | $534.7M | $604.3M | $648.4M | $693.8M | $747.2M |
| Property, Plant & Equipment, Net | $11.00M | $9.76M | $7.40M | $5.33M | $4.83M | $4.39M | $4.60M | $4.35M |
| Intangible Assets | $27.19M | $27.19M | $27.19M | $27.19M | $27.19M | $27.19M | $27.19M | $27.19M |
| Other Non-Current Assets | $9.69M | $15.43M | $15.43M | $13.36M | $9.36M | $9.30M | $10.41M | $9.75M |
| Total Non-Current Assets | $57.80M | $57.42M | $52.03M | $48.32M | $44.10M | $44.00M | $45.71M | $45.18M |
| Total Assets | $721.5M | $782.3M | $511.3M | $583.0M | $648.4M | $692.4M | $739.5M | $792.3M |
| Accounts Payable | $11.24M | $14.68M | $10.36M | $1.18M | $4.27M | $2.07M | $3.41M | $3.27M |
| Other Current Liabilities | $1.23M | $1.23M | $1.23M | $1.23M | $930K | $930K | $1.65M | $942K |
| Total Current Liabilities | $60.52M | $61.33M | $51.47M | $50.99M | $46.47M | $32.96M | $32.02M | $39.50M |
| Other Non-Current Liabilities | $3.11M | $3.11M | $3.11M | $4.04M | $2.54M | $2.54M | $2.54M | $3.47M |
| Total Non-Current Liabilities | $11.54M | $6.46M | $3.56M | $4.83M | $3.61M | $4.04M | $4.47M | $5.83M |
| Total Liabilities | $72.06M | $67.78M | $55.03M | $55.82M | $50.08M | $37.00M | $36.49M | $45.34M |
| Total Debt (incl. Leases) | $9.87M | $4.90M | $1.91M | $2.34M | $2.62M | $3.03M | $3.43M | $3.81M |
| Common Stock | $79K | $79K | $67K | $67K | $66K | $66K | $66K | $66K |
| Retained Earnings | -$2.04B | -$1.97B | -$1.89B | -$1.81B | -$1.73B | -$1.67B | -$1.61B | -$1.56B |
| Accumulated Other Comp. Income | -$329K | $1.30M | $2.52M | $3.63M | $3.77M | $3.34M | $3.57M | $3.31M |
| Total Stockholders' Equity | $649.5M | $714.6M | $456.2M | $527.2M | $598.4M | $655.4M | $703.0M | $747.0M |
| Total Equity | $649.5M | $714.6M | $456.2M | $527.2M | $598.4M | $655.4M | $703.0M | $747.0M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$258.8M | -$157.9M | -$141.4M | -- | -- | -- | -- | -- | -- | -- |
| Depreciation & Amortization | $3.38M | $3.18M | $3.01M | $2.90M | $3.07M | $3.93M | $4.86M | $3.58M | $4.41M | $3.10M |
| Stock-Based Compensation | $36.22M | $34.24M | $23.89M | $15.61M | $8.95M | $3.92M | $4.55M | $8.08M | $12.31M | $15.32M |
| Operating Cash Flow | -$210.9M | -$157.8M | -$107.3M | -$103.7M | -$60.91M | -$40.40M | -$46.41M | -$75.23M | -$99.93M | -$113.0M |
| Capital Expenditure | -$2.71M | -$1.92M | -$1.82M | -$1.83M | -$1.25M | -$1.55M | -$731K | -$813K | -$1.79M | -$2.75M |
| Free Cash Flow | -$213.7M | -$159.7M | -$109.1M | -$105.6M | -$62.16M | -$41.96M | -$47.15M | -$76.05M | -$101.7M | -$115.8M |
| Purchases of Investments | -$384.5M | -$789.9M | -$424.6M | -$189.0M | -$389.9M | -$220.3M | -$95.38M | -$171.2M | -$171.0M | -$173.9M |
| Investing Cash Flow | $209.1M | -$290.1M | -$105.8M | $89.94M | -$216.2M | -$98.22M | $17.08M | $29.82M | $46.47M | $68.91M |
| Common Stock Issued | -- | $432.3M | $216.2M | -- | $269.9M | $170.8M | $16.25M | $29.02M | $51.02M | $13.95M |
| Financing Cash Flow | $2.39M | $441.4M | $218.5M | $4.08M | $272.4M | $171.2M | $16.26M | $29.44M | $51.29M | $14.48M |
| Net Change in Cash | $515K | -$6.46M | $5.38M | -$9.71M | -$4.69M | $32.60M | -$13.08M | -$15.98M | -$2.17M | -$29.65M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$75.56M | -$73.50M | -$78.69M | -$81.32M | -$67.04M | -$56.60M | -$53.80M | -$47.09M |
| Depreciation & Amortization | $1.16M | $902K | $854K | $816K | $824K | $873K | $867K | $819K |
| Stock-Based Compensation | $10.97M | $8.41M | $8.52M | $8.91M | $8.80M | $9.19M | $9.32M | $9.78M |
| Operating Cash Flow | -$65.03M | -$57.41M | -$65.59M | -$63.94M | -$48.63M | -$44.01M | -$54.37M | -$32.48M |
| Capital Expenditure | -$1.67M | -$3.18M | -$1.64M | -$1.28M | -$440K | -$728K | -$265K | -$756K |
| Free Cash Flow | -$66.70M | -$60.59M | -$67.23M | -$65.22M | -$49.07M | -$44.73M | -$54.64M | -$33.23M |
| Purchases of Investments | -$62.21M | -$402.9M | -$59.61M | -$54.79M | -$55.63M | -$122.3M | -$151.8M | -$129.2M |
| Investing Cash Flow | $43.42M | -$255.5M | $72.12M | $55.42M | $60.85M | $49.85M | $42.95M | $24.05M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $0 |
| Financing Cash Flow | $1.11M | $324.7M | $327K | $1.35M | $774K | $63K | $202K | $386K |
| Net Change in Cash | -$20.50M | $11.72M | $6.86M | -$7.17M | $12.99M | $5.91M | -$11.22M | -$8.04M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 87.1% | 97.2% | 95.6% | 95.8% | 97.8% | 97.3% | 97.2% | 92.7% | 94.5% | 76.4% |
| Operating Margin | -18599.8% | -2778.9% | -2245.3% | -4889.0% | -1531.8% | -854.1% | -1540.2% | -1640.1% | -953.7% | -1958.7% |
| Net Profit Margin | -16748.0% | -2248.8% | -2054.8% | -4765.6% | -1516.0% | -805.9% | -1424.0% | -1585.1% | -730.1% | -1894.0% |
| Return on Equity (ROE) | -49.1% | -21.1% | -33.0% | -34.4% | -16.8% | -28.6% | -54.1% | -121.9% | -39.4% | -48.4% |
| Return on Assets (ROA) | -44.4% | -19.9% | -30.4% | -31.8% | -15.9% | -25.3% | -41.4% | -97.0% | -29.5% | -33.5% |
| Current Ratio | 10.49x | 18.91x | 13.87x | 17.07x | 24.86x | 13.93x | 5.73x | 7.86x | 5.22x | 5.55x |
| Quick Ratio | 10.17x | 18.36x | 13.61x | 16.39x | 24.70x | 13.69x | 5.53x | 7.46x | 5.03x | 5.39x |
| Debt to Equity | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | 0.04x | -- | -- | -- |
| Revenue Growth (YoY) | -78.0% | +2.0% | +192.0% | -49.3% | -37.3% | +107.6% | -62.5% | -25.2% | +87.8% | +23.8% |
| Gross Profit Growth (YoY) | -80.3% | +3.6% | +191.7% | -50.4% | -36.9% | +107.8% | -60.7% | -26.6% | +132.2% | -- |
| 5Y Revenue / Share Growth | -100.0% | -100.0% | -100.0% | +3280.7% | +10721.9% | +29448.6% | +40834.2% | +118071.5% | -48.9% | -71.5% |
| 10Y Revenue / Share Growth | -97.3% | -81.9% | -81.6% | +1626.6% | +2983.6% | +1036.3% | +2044.2% | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -211684.8% | -206220.3% | -35688.5% | -18587.7% | -9855.4% | -4053.7% | -2873.5% | -2778.9% |
| Net Profit Margin | -195608.9% | -190220.9% | -32753.6% | -16737.2% | -8635.8% | -3446.9% | -2366.1% | -2248.8% |
| Return on Equity (ROE) | -47.6% | -42.1% | -62.2% | -49.1% | -37.5% | -30.5% | -25.4% | -21.1% |
| Return on Assets (ROA) | -42.8% | -38.4% | -55.5% | -44.4% | -34.6% | -28.8% | -24.2% | -19.9% |
| Current Ratio | 10.97x | 11.82x | 8.92x | 10.49x | 13.01x | 19.67x | 21.67x | 18.91x |
| Quick Ratio | 10.75x | 11.70x | 8.77x | 10.17x | 12.55x | 19.12x | 21.03x | 18.36x |
| Debt to Equity | 0.02x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x |
| Revenue Growth (YoY) | -- | -97.0% | -97.8% | -89.7% | -100.0% | -70.8% | +345.5% | -71.6% |